Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $4.64 Million |
|---|---|
| Enterprise Value | $3.00 Million |
| Earnings per Share | $-0.01 |
| Beta | 1.17 |
| Outstanding Shares | 1,547,790,450 |
| P/E Ratio | -0.53 |
|---|---|
| PEG | -0.81 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.6 |
| Enterprise Value to EBIT | -0.19 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.14 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Verici Dx plc is an immuno-diagnostics developer primarily dedicated to innovations within the kidney transplantation field. It creates both prognostic (predictive) and diagnostic (identifying current conditions) assays specifically desi...